FDA Adverse Event Malfunction Summary report: N

WALLSTENT RX BILIARY ENDOPROSTHESIS

MDR report key: 1052545 · Received May 22, 2008

Report

Report Number
3005099803-2008-00520
Event Type
Malfunction
Date Received
May 22, 2008
Date of Event
February 29, 2008
Report Date
April 24, 2008
Manufacturer
BOSTON SCIENTIFIC IRELAND, LTD.
Product Code
FGE
PMA / PMN Number
K012752
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

NOTE: THE EVENT, AS REPORTED, DID NOT REFLECT AN MDR-REPORTABLE SCENARIO; HOWEVER, EVALUATION OF THE RETURNED DEVICE, WHICH WAS COMPLETED ON APRIL 24, 2008, REVEALED AN MDR-REPORTABLE MALFUNCTION. THIS MANUFACTURER REPORT IS SUBMITTED BASED ON THE EVALUATION RESULTS. VISUAL EXAMINATION OF THE RETURNED DEVICE REVEALED THAT SEVERAL STENTS WIRES HAD PERFORATED THE OUTER SHEATH (SEE FIGURE 1, PAGE 3). THE CAUSE OF THE DAMAGE IS UNKNOWN. THE DEVICE HISTORY RECORD (DHR) FOR THE PERTINENT LOT WAS REVIEWED; NO ANOMALIES WERE NOTED. A SEARCH OF THE COMPLAINT DATABASE REVEALED TWO ADDITIONAL COMPLAINTS RECORDED FOR THIS LOT (FOR THE SAME FAILURE MODE). THE APRIL 2008 15-MONTH RX BILIARY STENT PRODUCT FAMILY COMPLAINT TREND REPORT, INCLUSIVE OF ALL FAILURE MODES, WAS REVIEWED; NO UNFAVORABLE TREND WAS NOTED.

Description of Event or Problem · 1

A WALLSTENT RX BILIARY ENDOPROSTHESIS WAS USED DURING A BILIARY STENT PLACEMENT PROCEDURE IN AN ADULT FEMALE PATIENT (AGE AND WEIGHT UNKNOWN) IN 2008. ACCORDING TO THE COMPLAINANT, THE OUTER SHEATH COULD NOT BE RETRACTED (AS INTENDED) TO DEPLOY THE STENT. THE PHYSICIAN USED A SECOND WALLSTENT RX BILIARY ENDOPROSTHESIS TO SUCCESSFULLY COMPLETE THE PROCEDURE. THERE WERE NO PATIENT COMPLICATIONS AS A RESULT OF THIS EVENT, AND THE PATIENT'S CONDITION WAS REPORTED AS "GOOD" FOLLOWING THE PROCEDURE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 WALLSTENT RX BILIARY ENDOPROSTHESIS FGE BOSTON SCIENTIFIC IRELAND, LTD. M00569710 11365293

Patients

Seq Age Sex Outcome Treatment
1 UNK